FAVA, MARCO
FAVA, MARCO
Universita' degli Studi di MILANO
Epidemiology, Clinical Manifestations, and Outcome of Mucormycosis in Solid Organ Transplant Recipients: A Systematic Review of Reported Cases
2024 E. Palomba, M. Colaneri, C. Azzarà, M. Fava, A. Maccaro, G. Renisi, G. Viero, H. Kaur, A. Chakrabarti, A. Gori, A. Lombardi, A. Bandera
Preliminary Evidence of Good Safety Profile and Outcomes of Early Treatment With Tixagevimab/Cilgavimab Compared to Previously Employed Monoclonal Antibodies for COVID-19 in Immunocompromised Patients
2023 A. Lombardi, G. Viero, S. Villa, S. Biscarini, E. Palomba, C. Azzara', N. Iannotti, B. Mariani, C. Genovese, M. Tomasello, A. Tonizzo, M. Fava, A. Grazia Valzano, L. Morlacchi, M. Francesca Donato, G. Castellano, R. Cassin, M. Carrabba, A. Muscatello, A. Gori, A. Bandera
Preliminary Evidence of Good Safety Profile and Outcomes of Early Treatment with Tixagevimab/Cilgavimab Compared to Previously Employed Monoclonal Antibodies for COVID-19 in Immunocompromised Patients
2023 A. Lombardi, G. Viero, S. Villa, S. Biscarini, E. Palomba, C. Azzarà, N. Iannotti, B. Mariani, C. Genovese, M. Tomasello, A. Tonizzo, M. Fava, A. Grazia Valzano, L.C. Morlacchi, M. Francesca Donato, G. Castellano, R. Cassin, M. Carrabba, A. Muscatello, A. Gori, A. Bandera
Safety Profile and Outcomes of Early COVID-19 Treatments in Immunocompromised Patients: A Single-Centre Cohort Study
2022 S. Biscarini, S. Villa, C. Genovese, M. Tomasello, A. Tonizzo, M. Fava, N. Iannotti, M.M. Bolis, B. Mariani, A. Grazia Valzano, L.C. Morlacchi, F. Donato, G. Castellano, R. Cassin, M.D.R. Carrabba, A. Muscatello, A. Gori, A. Bandera, A. Lombardi
Mucormycosis in CAPA, a possible fungal super-infection
2021 P. Saltini, E. Palomba, V. Castelli, M. Fava, L. Alagna, S. Biscarini, M. Mantero, F.B.A. Blasi, A. Grancini, A. Bandera, A. Gori, A. Muscatello, A. Lombardi